Brilliant Violet 605™ anti-mouse CD11c Antibody

Product Details

Verified Reactivity

Mouse

Antibody Type

Monoclonal

Host Species

Armenian Hamster

Immunogen

Mouse spleen dendritic cells

Formulation

Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA).

Preparation

The antibody was purified by affinity chromatography and conjugated with Brilliant Violet 605™ under optimal conditions.

Concentration

µg sizes: 0.2 mg/mL
µL sizes: lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.)

Storage & Handling

The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.

Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For immunofluorescent staining using the µg size, the suggested use of this reagent is ≤0.25 µg per million cells in 100 µl volume. For immunofluorescent staining using the µl size, the suggested use of this reagent is 5 µl per million cells in 100 µl staining volume or 5 µl per 100 µl of whole blood. It is recommended that the reagent be titrated for optimal performance for each application.

Brilliant Violet 605™ excites at 405 nm and emits at 603 nm. The bandpass filter 610/20 nm is recommended for detection, although filter optimization may be required depending on other fluorophores used. Be sure to verify that your cytometer configuration and software setup are appropriate for detecting this channel. Refer to your instrument manual or manufacturer for support. Brilliant Violet 605™ is a trademark of Sirigen Group Ltd.

Learn more about Brilliant Violet™.

This product is subject to proprietary rights of Sirigen Inc. and is made and sold under license from Sirigen Inc. The purchase of this product conveys to the buyer a non-transferable right to use the purchased product for research purposes only. This product may not be resold or incorporated in any manner into another product for resale. Any use for therapeutics or diagnostics is strictly prohibited. This product is covered by U.S. Patent(s), pending patent applications and foreign equivalents.

Excitation Laser

Violet Laser (405 nm)

Application Notes

Additional reported applications (for the relevant formats) include: immunoprecipitation³, immunohistochemical staining of acetone-fixed frozen sections³, immunofluorescence microscopy^{5, 9} (Alexa Fluor® 488 conjugated N418 was used for IHC in frozen sections¹⁰), and spatial biology (IBEX)^22,23.

Application References

(PubMed link indicates BioLegend citation)

1. Granucci F, et al. 1997. J. Immunol. 159:1794.
2. Stokes RW, et al. 1998. J. Immunol. 160:5514.
3. Metlay JP, et al. 1990. J. Exp. Med. 171:1753. (IHC, IP)
4. Ma XT, et al. 2006. Cancer Research 66:1169.
5. Chin RK, et al. 2006. J. Immunol. 177:290. (IF)
6. Cervantes-Barragan L, et al. 2007. Blood 109:1131. (FC) PubMed
7. Turnquist HR, et al. 2007. J. Immunol. 178:7018. (FC) PubMed
8. Benson MJ, et al. 2007. J. Exp. Med. doi:10.1084/jem.20070719. (FC) PubMed
9. You Y, et al. 2009. J. Immunol. 182:7343. (IF) PubMed
10. Roland CL, et al. 2009. Mol. Cancer Res. 8:1761. (IHC, FC) PubMed
11. Wikstrom M, et al.2006. J. Immunol. 177:913. PubMed
12. Pericolini E, et al. 2008. J. Leukocyte Biol. 83:1286. PubMed
13. Randall LM, et al. 2008. Infect. Immun.76:3312. PubMed
14. Fahlen-Yrild L, et al. 2009. J. Immunol. 183:5032. PubMed
15. Osterholzer JJ, et al. 2009. J. Immunol. 183:8044. PubMed
16. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
17. Eisenach PA, et al. 2010. J Cell Sci. 123:4182. PubMed
18. Leppin K, et al. 2014. Invest. Ophthalmol. Vis. Sci. 55:3603. PubMed
19. Sakai F, et al. 2014. PLoS One. 9:105370. PubMed
20. Gibbins JD, et al. 2014. Blood. 124:2953. PubMed
21. White CE, et al. 2015. J Immunol. 194:697. PubMed
22. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
23. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
24. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed

Product Citations

1. Miranda K, et al. 2022. iScience. 25:104994. PubMed
2. Bergot AS, et al. 2020. J Immunol. 204:1787. PubMed
3. Bruand M, et al. 2021. Cell Reports. 36(3):109412. PubMed
4. Hulsebus HJ, et al. 2022. Front Immunol. 13:884719. PubMed
5. Wong Fok Lung T, et al. 2020. Nat Microbiol. 141:5. PubMed
6. Minutti CM, et al. 2019. Immunity. 50:645. PubMed
7. Manivasagam S, et al. 2022. J Immunol. 208:1341. PubMed
8. Sepe JJ, et al. 2022. JACC Basic Transl Sci. 7:915. PubMed
9. Piper CJM, et al. 2020. Cell Reports. 29(7):1878-1892.e7.. PubMed
10. Chow MT et al. 2019. Immunity. 50(6):1498-1512 . PubMed
11. Álvaro de Mingo Pulido et al. 2018. Cancer cell. 33(1):60-74 . PubMed
12. Chen J, et al. 2022. Nat Commun. 13:6759. PubMed
13. Stolp B, et al. 2022. Cell Rep. 38:110387. PubMed
14. Park JG, et al. 2021. iScience. 24(9):102941. PubMed
15. de Mingo Pulido , et al. 2021. Immunity. 54(6):1154-1167.e7. PubMed
16. Almutairi F, et al. 2021. Front Immunol. 12:772288. PubMed
17. Xu AQ, et al. 2020. Elife. 9:00. PubMed
18. Kienzl M, et al. 2020. Oncoimmunology. 9:1776059. PubMed
19. Zhuo M, et al. 2021. Pigment Cell Melanoma Res. 34:605. PubMed
20. Mastandrea I, et al. 2022. STAR Protoc. 3:101106. PubMed
21. Dodagatta-Marri E, et al. 2021. Cell Rep. 36:109309. PubMed
22. Magod P, et al. 2021. Cell Reports. 36(5):109480. PubMed
23. Perner C, et al. 2020. Immunity. 53(5):1063-1077.e7. PubMed
24. Ellis G, et al. 2015. EMBO Rep. 16: 1203-1218. PubMed
25. Wiesner D, et al. 2015. PLoS Pathog. 11:1004701. PubMed
26. Ratitong B, et al. 2021. Cell Reports. 35(7):109139. PubMed
27. Li J, et al. 2020. Cancer Discov. . PubMed
28. Lagares D, et al. 2017. Sci Transl Med. 9:eaal3765. PubMed
29. McAlpine CS, et al. 2021. Nature. 595:701. PubMed
30. Tomlinson KL, et al. 2021. Nat Commun. 12:1399. PubMed
31. Forbester JL, et al. 2020. J Virol. 94:. PubMed
32. Aegerter H, et al. 2020. Nat Immunol. 0.975694444. PubMed
33. Li J, et al. 2020. Cancer Immunol Res. 0.529166667. PubMed
34. Wang ECE, et al. 2019. Cell Stem Cell. 24:654. PubMed
35. Pereira JA, et al. 2020. Hum Mol Genet. 29:1253. PubMed
36. Li J, et al. 2018. Immunity. 49:178. PubMed
37. Riquelme SA, et al. 2020. Cell Metabolism. 31(6):1091-1106.e6. PubMed
38. Sutherland TE, et al. 2021. Frontiers in Immunology. 12:715209. PubMed
39. Guo Y, et al. 2020. Cell Host & Microbe. 28(1):104-116.e4.. PubMed
40. Acker KP, et al. 2019. iScience. 19:281. PubMed
41. , et al. 2021. Eur J Immunol. 51:2708. PubMed
42. Medler TR et al. 2018. Cancer cell. 34(4):561-578 . PubMed
43. Macdougall CE et al. 2018. Cell metabolism. 27(3):588-601 . PubMed
44. Pennock ND, et al. 2018. J Immunother Cancer. 0.318055556. PubMed
45. Jorapur A, et al. 2022. PLoS Pathog. 18:e1010200. PubMed
46. Pundir P, et al. 2020. Cell Host & Microbe. 26(1):114-122. PubMed
47. Kyburz A, et al. 2019. J Allergy Clin Immunol. 143:1496. PubMed
48. Yu X, et al. 2019. Nat Commun. 10:574. PubMed
49. Becker W, et al. 2021. J Crohns Colitis. 15:1032. PubMed
50. Olson GS, et al. 2021. Cell Reports. 35(9):109195. PubMed
51. Dewi IMW, et al. 2021. Cell Reports Medicine. 2(5):100289. PubMed
52. Spix B, et al. 2022. Nat Commun. 13:318. PubMed
53. Gamrekelashvili J, et al. 2021. Bio Protoc. 11:e4007. PubMed
54. Muri J, et al. 2020. eLife. 9:e53627.. PubMed
55. Dangaj D, et al. 2019. Cancer Cell. 35:885. PubMed
56. Engblom C, et al. 2017. Science. 358:6367. PubMed
57. Hu X, et al. 2021. JCI Insight. 6:. PubMed
58. Teo TH, et al. 2018. Nat Commun. 9:3905. PubMed
59. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
60. Dallari S, et al. 2021. Cell Host Microbe. 29(6):1014-1029.e8. PubMed
61. Lang JF et al. 2019. Nat Commun. 10(1):3415 . PubMed
62. Wang R, et al. 2022. J Immunother Cancer. 10:. PubMed
63. Hackstein CP, et al. 2022. Nat Commun. 13:7472. PubMed
64. Nicolas-Boluda A, et al. 2021. eLife. 10:00. PubMed
65. Santopaolo M, et al. 2021. Front Immunol. 609406:12. PubMed
66. Fleskens V, et al. 2019. Cell Rep. 26:3600. PubMed
67. Koyama M et al. 2019. Immunity. 51(5):885-898 . PubMed
68. Phadke MS, et al. 2021. Cancer Immunol Res. 9:554. PubMed
69. Rappe JCF, et al. 2021. J Exp Med. 218:. PubMed
70. Gardner A, et al. 2022. J Immunother Cancer. 10:. PubMed
71. Subramanian S, et al. 2022. Nat Immunol. 23:458. PubMed
72. Kastenschmidt JM, et al. 2021. Cell Rep. 35:108997. PubMed
73. Ehrens A, et al. 2021. Cell Reports. 34(2):108621. PubMed
74. McGinley AM, et al. 2020. Immunity. 52(2):342-356. PubMed
75. Fearon AE, et al. 2021. iScience. 24:103143. PubMed
76. Celias DP, et al. 2022. STAR Protoc. 3:101464. PubMed
77. Goddery EN, et al. 2021. Front Immunol. 12:726421. PubMed
78. Allman W, et al. 2015. Proc Natl Acad Sci U S A. 112: 4094 - 4103. PubMed

RRID

AB_11204262 (BioLegend Cat. No. 117333)
AB_2562415 (BioLegend Cat. No. 117334)

Antigen Details

Structure

Integrin α-chain, associates with integrin β₂ (CD18), 150 kD

Distribution

Dendritic cells, NK cells, intestinal intraepithelial lymphocytes (IEL), some activated T cells

Function

Cellular adhesion

Ligand/Receptor

iC3b, fibrinogen

Cell Type

Dendritic cells, Epithelial cells, NK cells, T cells, Tregs

Biology Area

Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers

Molecular Family

Adhesion Molecules, CD Molecules

Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen Facts Book Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Lopez-Rodriguez C, et al. 1996. J. Immunol. 156:3780.

Gene ID

16411 View all products for this Gene ID

UniProt

View information about CD11c on UniProt.org

Documentation

• Technical data sheet
• Certificate of Analysis
• Safety Data Sheet

Reviews

Related Protocols

• Cell Surface Flow Cytometry Staining Protocol

Related Pages & Pathways

Related FAQs

Other Formats

Certificate of Analysis